Pharmacokinetics-Based Optimization of Phototherapy in Neonates Undergoing Treatment for Hyperbilirubinemia

Dibyajyoti Saikia1, Subodh Kumar2, T Velpandian3

  • 1Department of Pharmacology, Noida International Institute of Medical Sciences, Greater Noida, India.

Maedica
|March 9, 2022
PubMed

Insights

This study investigated the relationship between phototherapy irradiance and serum bilirubin reduction in neonates. Findings suggest the efficacy of phototherapy is unlikely to be linear with irradiance, with data insufficient to distinguish proportionality from saturation.

Area of Science:

  • Neonatal Medicine
  • Biochemistry
  • Medical Physics

Background:

  • Neonatal jaundice is a common condition caused by increased bilirubin production and immature hepatic excretion.
  • Phototherapy is the standard treatment, but its dose-response relationship requires further elucidation.
  • Understanding the irradiance-efficacy relationship is crucial for optimizing jaundice management.

Discussion:

  • This study explored the relationship between phototherapy irradiance and serum bilirubin reduction in neonates.
  • Infants received varying phototherapy doses, with bilirubin levels monitored over 12 hours.
  • Serum bilirubin concentrations were quantified using HPLC and LC-MS/MS.

Key Insights:

  • The reduction in serum bilirubin during phototherapy is unlikely to be linear with increasing irradiance.
  • Collected data suggest a potential plateau or saturation effect at higher irradiance levels.
  • Further research is needed to definitively distinguish between proportionality and saturation in phototherapy efficacy.

Outlook:

  • Future studies should aim to collect more data to clarify the exact relationship between phototherapy irradiance and bilirubin reduction.
  • Investigating optimal phototherapy protocols based on irradiance levels could improve treatment outcomes.
  • Exploring alternative or adjunctive therapies for neonatal jaundice remains an important area of research.

Related Concept Videos

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
326
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
616
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.5K
Chronopharmacokinetics: Time-Dependent Pharmacokinetics01:20

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
236
Nonlinear Pharmacokinetics: Causes of Nonlinearity01:22

Nonlinear Pharmacokinetics: Causes of Nonlinearity

Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
375
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
147